Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$4.95 - $9.16 $346,500 - $641,200
-70,000 Reduced 13.01%
468,152 $3.51 Million
Q1 2022

May 02, 2022

BUY
$5.64 - $9.8 $342,359 - $594,879
60,702 Added 12.71%
538,152 $4.9 Million
Q4 2021

Feb 10, 2022

BUY
$7.02 - $13.33 $468,121 - $888,897
66,684 Added 16.23%
477,450 $3.35 Million
Q3 2021

Nov 03, 2021

BUY
$11.32 - $16.63 $1.25 Million - $1.84 Million
110,675 Added 36.88%
410,766 $4.68 Million
Q2 2021

Jul 30, 2021

SELL
$15.16 - $18.97 $589,633 - $737,819
-38,894 Reduced 11.47%
300,091 $4.8 Million
Q1 2021

May 13, 2021

SELL
$13.12 - $20.9 $1.77 Million - $2.82 Million
-134,913 Reduced 28.47%
338,985 $6.06 Million
Q4 2020

Feb 12, 2021

BUY
$9.12 - $14.49 $498,380 - $791,835
54,647 Added 13.03%
473,898 $6.4 Million
Q3 2020

Nov 06, 2020

BUY
$10.46 - $14.46 $1.81 Million - $2.51 Million
173,418 Added 70.54%
419,251 $4.94 Million
Q2 2020

Aug 03, 2020

BUY
$12.0 - $16.13 $1.76 Million - $2.37 Million
146,667 Added 147.9%
245,833 $3.63 Million
Q1 2020

May 14, 2020

BUY
$11.84 - $25.52 $586,423 - $1.26 Million
49,529 Added 99.78%
99,166 $1.34 Million
Q4 2019

Feb 10, 2020

BUY
$17.72 - $25.1 $879,567 - $1.25 Million
49,637 New
49,637 $1.2 Million
Q2 2019

Aug 07, 2019

SELL
$28.97 - $48.21 $8.13 Million - $13.5 Million
-280,778 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$36.32 - $49.25 $10.2 Million - $13.8 Million
280,778 New
280,778 $13.3 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.